Skip to main content
. 2016 Feb 12;33:25. doi: 10.1007/s12032-016-0738-8

Table 2.

Demographic analysis of patient groups

Parameter All patients Group 1 (≤4 days) Group 2 (>4 days) p value
Number of patients, n (%) 143 75 (52.4 %) 68 (47.6 %)
Females, n (%) 68 (47.6 %) 39 (52 %) 29 (42.6 %) 0.26
Males, n (%) 75 (52.4 %) 36 (48 %) 39 (57.4 %)
Mean age, years ± SD 66.8 ± 12.6 65.9 ± 12.9 67.3 ± 12.3 0.35
BMI, kg/m2 ± SD 25.9 ± 4.9 26.5 ± 5.3 25.2 ± 4.5 0.24
ASA 1, n (%) 5 (3.5 %) 4 (5.3 %) 1 (1.5 %) 0.14
ASA 2, n (%) 87 (60.9 %) 44 (58.7 %) 43 (63.2 %)
ASA 3, n (%) 47 (32.8 %) 23 (30.7 %) 24 (35.3 %)
ASA 4, n (%) 4 (2.8 %) 4 (5.3 %) 0 (0 %)
Any comorbidity, n (%) 109 (76.2 %) 54 (72.0 %) 55 (80.9 %) 0.21
Cardiovascular, n (%) 52 (36.4 %) 25 (33.3 %) 27 (39.7 %) 0.92
Hypertension, n (%) 74 (51.7 %) 39 (52.0 %) 35 (51.5 %) 0.95
Diabetes, n (%) 28 (19.6 %) 15 (20 %) 13 (19.1 %) 0.89
Pulmonary, n (%) 21 (14.7 %) 9 (12.0 %) 12 (17.6 %) 0.34
Renal, n (%) 12 (8.4 %) 7 (9.3 %) 5 (7.4 %) 0.67
Liver, n (%) 5 (3.5 %) 1 (1.3 %) 4 (5.9 %) 0.14
Distance from the place of residence <50 km, n (%) 103 (72 %) 52 (69.3 %) 51 (75.0 %) 0.33
Distance from the place of residence >50 km, n (%) 40 (28 %) 23 (30.1 %) 17 (25.0 %)
Colonic resection, n (%) 100 (69.9 %) 56 (74.7 %) 44 (64.7 %) 0.19
TME, n (%) 43 (30.1 %) 19 (25.3 %) 24 (35.3 %) 0.50
AJCC Stage I, n (%) 45 (31.5 %) 27 (36 %) 18 (26.5 %)
AJCC Stage II, n (%) 49 (34.2 %) 26 (34.7 %) 23 (33.8 %)
AJCC Stage III, n (%) 34 (23.8 %) 16 (21.3 %) 18 (26.5 %)
AJCC Stage IV, n (%) 15 (10.5 %) 6 (8 %) 9 (13.2 %)
Mean length of hospital stay, days (range) 5.5 (2–40) 2.9 (2–4) 8.4 (5–40)
Median length of hospital stay, days (IQR) 4 (3–7) 3 (2–3) 7 (5–8)
Mean operative time, min ± SD 185.1 ± 62.2 185.4 ± 51.3 184.8 ± 73.8 0.49
Mean intraoperative blood loss, ml ± SD 90.2 ± 79.5 84.3 ± 74.1 97 ± 86.1 0.36
Conversion, n (%) 3 (2.1 %) 0 3 (4.4 %)

AJCC American Joint Committee on Cancer, ASA American Society of Anaesthesiologists, SD standard deviation, IQR interquartile range